Hayes Kate, Hodgson Carol L, Pellegrino Vincent A, Snell Greg, Tarrant Benjamin, Fuller Louise M, Holland Anne E
Department of Physiotherapy, The Alfred Hospital, Melbourne, Victoria, Australia.
Discipline of Physiotherapy, La Trobe University, Melbourne, Victoria, Australia.
Respir Care. 2018 Feb;63(2):194-202. doi: 10.4187/respcare.05334. Epub 2017 Oct 31.
Extracorporeal membrane oxygenation (ECMO) is used as a rescue therapy before and after lung transplantation, but little is known about functional recovery or complications after ECMO in this cohort. This study aimed to describe early physical function and leg complications in subjects who received ECMO before or after lung transplantation, and to compare functional outcomes to a matched cohort of subjects who did not require ECMO.
A retrospective study was conducted over 2 years. Highest mobility level was assessed, in both the ECMO and non-ECMO groups, prior to ICU admission, at ICU discharge, and at hospital discharge, while 6-min walk distance was measured at hospital discharge and at 3 months. Strength was assessed at ICU discharge and at hospital discharge in the ECMO subjects only, and leg complications were recorded up until hospital discharge.
17 subjects (mean age 43 ± 13 y; 65% (11 of 17 subjects) female) required ECMO before or after lung transplant. Survival to hospital discharge was 82% (14 of 17 subjects). At ICU discharge, strength and mobility levels were poor, but both improved by hospital discharge ( < .001). Leg complications were reported in 50% of survivors (7 of 14 subjects). ECMO survivors spent longer in the ICU ( < .001) and hospital ( = .002) and had worse physical function (ie, lower mobility level at ICU discharge, mean difference -1, = .02; 6-min walk distance at hospital discharge: mean difference -99 m, = .004) than lung transplant recipients not requiring ECMO ( = 28).
In subjects requiring ECMO before or after lung transplantation, 82% survived to hospital discharge, but leg complications were common and physical function was poor at ICU discharge. Physical function improved over time, however subjects who required ECMO had a longer period of hospitalization and worse physical function at ICU and hospital discharge than those who did not require ECMO.
体外膜肺氧合(ECMO)被用作肺移植前后的一种挽救治疗方法,但对于该队列中接受ECMO治疗后的功能恢复或并发症情况知之甚少。本研究旨在描述在肺移植前后接受ECMO治疗的受试者的早期身体功能和腿部并发症,并将功能结局与未接受ECMO治疗的匹配队列受试者进行比较。
进行了一项为期2年的回顾性研究。在ECMO组和非ECMO组中,于重症监护病房(ICU)入院前、ICU出院时和医院出院时评估最高活动水平,同时在医院出院时和3个月时测量6分钟步行距离。仅在ECMO受试者的ICU出院时和医院出院时评估肌力,并记录直至医院出院时的腿部并发症情况。
17名受试者(平均年龄43±13岁;65%(17名受试者中的11名)为女性)在肺移植前后需要ECMO治疗。医院出院时的生存率为82%(17名受试者中的14名)。在ICU出院时,肌力和活动水平较差,但到医院出院时均有所改善(P<.001)。50%的幸存者(14名受试者中的7名)报告有腿部并发症。与不需要ECMO的肺移植受者(n = 28)相比,接受ECMO治疗的幸存者在ICU(P<.001)和医院(P = .002)的住院时间更长,身体功能更差(即ICU出院时活动水平更低,平均差异-1,P = .02;医院出院时6分钟步行距离:平均差异-99 m,P = .004)。
在肺移植前后需要ECMO治疗的受试者中,82%存活至医院出院,但腿部并发症常见,且在ICU出院时身体功能较差。随着时间推移身体功能有所改善,然而,与不需要ECMO的受试者相比,需要ECMO的受试者住院时间更长,在ICU和医院出院时身体功能更差。